Breast cancer
Drug Name
- ABRAXANE
- AFINITOR
- ANDROXY
- ARIMIDEX
- AROMASIN
- Cyclophosphamide
- Cyclophosphamide Injection
- Doxorubicin HCl
- Doxorubicin HCl Solution
- ELLENCE
- ESTRACE
- EVISTA
- FARESTON
- FASLODEX
- FEMARA
- Fixed-Dose Trastuzumab in Early-Stage HER2-Positive Breast Cancer: Unanswered Questions
- Fluorouracil
- Fluoxymesterone
- GEMZAR
- HALAVEN
- HERCEPTIN
- Herceptin Hylecta Approved for the Treatment of HER2-Overexpressing Breast Cancer
- IBRANCE
- IXEMPRA
- KADCYLA
- KISQALI
- KISQALI FEMARA CO-PACK
- LYNPARZA TABLETS
- Megestrol Tablets
- Methotrexate for injection
- Methotrexate injection
- NERLYNX
- Pamidronate disodium Injection
- PERJETA
- Phthalates and Postmenopausal Breast Cancer
- PREMARIN
- SOLTAMOX ORAL SOLUTION
- TALZENNA
- Tamoxifen
- TAXOL
- TAXOTERE
- TECENTRIQ
- TEPADINA
- Testosterone Enanthate
- Thiotepa
- Trazimera, a Biosimilar to Herceptin, Gets FDA Approval
- TREXALL
- Tumor Hypoxia and Breast Cancer Risk
- Tumor-Infiltrating Lymphocytes and Prognosis in Early-Stage TNBC
- TYKERB
- VERZENIO
- Vinblastine for injection
- Vinblastine injection
- VITRAKVI
- VITRAKVI ORAL SOLUTION
- XELODA
- ZOLADEX
